TNYA
Price:
$2.38
Market Cap:
$188.54M
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
TNYA
According to Tenaya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 194.85M. This represents a change of -19.08% compared to the average of 240.79M of the last 4 quarters.
The mean historical Enterprise Value of Tenaya Therapeutics, Inc. over the last ten years is 416.78M. The current 194.85M Enterprise Value has changed 4.58% with respect to the historical average. Over the past ten years (40 quarters), TNYA's Enterprise Value was at its highest in in the December 2021 quarter at 757.34M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
416.78M
Median
502.73M
Minimum
9.92M
Maximum
758.05M
Discovering the peaks and valleys of Tenaya Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.97%
Maximum Annual Enterprise Value = 758.05M
Minimum Annual Increase = -98.69%
Minimum Annual Enterprise Value = 9.92M
Year | Enterprise Value | Change |
---|---|---|
2023 | 205.81M | 1.97% |
2022 | 9.92M | -98.69% |
2021 | 758.05M | 50.79% |
2020 | 502.73M | -17.23% |
The current Enterprise Value of Tenaya Therapeutics, Inc. (TNYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
324.59M
5-year avg
416.78M
10-year avg
416.78M
Tenaya Therapeutics, Inc.’s Enterprise Value is less than Bicycle Therapeutics plc (537.81M), less than IGM Biosciences, Inc. (531.62M), less than Monte Rosa Therapeutics, Inc. (439.72M), less than Stoke Therapeutics, Inc. (457.69M), greater than Biomea Fusion, Inc. (154.99M), less than Akero Therapeutics, Inc. (2.00B), greater than Homology Medicines, Inc. (-103303255.00), less than Gossamer Bio, Inc. (331.04M), greater than Rani Therapeutics Holdings, Inc. (148.90M), greater than Vincerx Pharma, Inc. (7.15M), less than Corvus Pharmaceuticals, Inc. (570.78M), greater than ALX Oncology Holdings Inc. (68.10M), greater than Eyenovia, Inc. (15.12M), greater than Alpha Tau Medical Ltd. (169.26M), less than Ocular Therapeutix, Inc. (1.04B), less than Inozyme Pharma, Inc. (202.73M),
Company | Enterprise Value | Market cap |
---|---|---|
537.81M | $1.42B | |
531.62M | $528.64M | |
439.72M | $521.60M | |
457.69M | $605.41M | |
154.99M | $233.38M | |
2.00B | $2.28B | |
-103303255.00 | $3.02M | |
331.04M | $157.63M | |
148.90M | $119.45M | |
7.15M | $8.46M | |
570.78M | $575.10M | |
68.10M | $74.37M | |
15.12M | $9.30M | |
169.26M | $162.22M | |
1.04B | $1.39B | |
202.73M | $180.51M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenaya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tenaya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Tenaya Therapeutics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Tenaya Therapeutics, Inc. (TNYA)?
What is the 3-year average Enterprise Value for Tenaya Therapeutics, Inc. (TNYA)?
What is the 5-year average Enterprise Value for Tenaya Therapeutics, Inc. (TNYA)?
How does the current Enterprise Value for Tenaya Therapeutics, Inc. (TNYA) compare to its historical average?